Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
These third-party marketers earn commissions from their insurer clients not only upon initial signups but also every time “their” enrollees renew without changing plans.
The company made the changes after its manufacturer rebates for insulin were challenged by the Federal Trade Commission. Among other shifts, Optum said 100% of all rebates will be distributed to customers by 2028.
The Patients Before Monopolies Act was introduced into both the U.S. Senate and House of Representatives with bipartisan support. If it passes, pharmacy benefit managers would be required to divest from retail stores.
The Centers for Medicare & Medicaid Services said it’s issuing a nationwide moratorium on new providers entering the spaces until it has a chance to look into allegations of fraud, waste and abuse. It confirmed investigations of various organizations are pending.
ChatGPT and similar technologies coming down the medical pike have far to go before they’re reliable sources of accurate and appropriate health information. That doesn’t mean they’re non-factors now.
The CEO of Cardiovascular Associates of America, and former CEO of the American College of Cardiology, shared his perspective on the rise of private equity investments in cardiology.
Having renewed its partnerships with US Ski & Snowboard, US Speedskating and USA Bobsled/Skeleton, Minneapolis-based Rayus Radiology will continue to serve as an official medical provider for athletes represented by all three.
Welcome to Movers & Shakers, a roundup of the latest executive movements in the healthcare space, featuring Johnson & Johnson, Community Healthcare Trust and Emids.